David Rubenstein interviewed Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson. The dinner was held on Tuesday, June 16, 2026.
Under Joaquin Duato’s leadership, Johnson & Johnson has sharpened its focus on healthcare innovation by developing breakthrough medicines and medical technology solutions for some of the world's most complex diseases. Duato has served for over three decades with the company, working across multiple geographies, functions, and business segments.
A dual citizen of the United States and Spain, Joaquin earned an MBA from ESADE in Barcelona and a Master of International Management from the Thunderbird School of Global Management in Phoenix, Arizona. In 2023, King Felipe VI of Spain honored him with the Order of Civil Merit, Commander by Number.
The company’s approximately 138,000 employees work to transform health by building a world where complex diseases are prevented, treated, and cured, and where solutions are smarter, less invasive, and more personalized. Johnson & Johnson is accelerating healthcare innovation using data science and the latest technology to create breakthroughs in care, from cell therapy to robotic-assisted surgery.
